Company: RGNT
Filing Date: 2025-05-19
Form Type: F-1/A
Source: 0001213900-25-045479
Chunk: 192

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-05-19
Form: F-1/A
Chunk 192
---
eller.                                    |
| (5) | Consists of 261,020 Ordinary                                                                                                                 
 Shares. The beneficial owner under DSM is DSM Nederland B.V., which is 100% owned by Koninklijke DSM N.V. (or Royal DSM). Koninklijke        
 DSM N.V. is a publicly traded company with Ordinary Shares listed on NYSE Euronext stock exchange in Amsterdam. Koninklijke DSM N.V.         
 currently has no controlling shareholders. The company is managed by a Managing Board together with an Executive Committee and an            
 independent Supervisory Board. Members of the Managing Board and the Supervisory Board are appointed by the General Meeting of Shareholders. 
 The business address of this stockholder is 1 Het Overloon, 6411 TE Heerlen, Netherlands.                                                    |
| (6) | Consists of (1) 261,780                                                                                                                      
 Ordinary Shares owned by the Medica III Investments (International) L.P, (2) 95,153 Ordinary Shares owned by Medica III Investments          
 (Israel) LP; (iii) 103,405 Ordinary Shares owned by Medica III Investments (SF) LP; (iv) 55,655 Ordinary shares owned by Medica III          
 Investments (PF) LP; (v) 134,430 Ordinary Shares owned by Medica III Investments Israel (B) LP; (vi) 124,090 Ordinary Shares owned           
 by Poalim Medica III Investments LP. The beneficial owners under Medica Group are: MCP Opportunity Secondary Program III L.P with            
 10.57% beneficial ownership, NYC Police Pension Fund with 8.8% beneficial ownership, Quantum Partners LDC with 13.2% beneficial ownership,   
 and Migdal Insurance Company Ltd with 8.8% beneficial ownership. None of which include individuals who hold more than 5% interest.           
 Medica III Management L.P., an entity held 50% by Dr. Ehud Geller and 50% by Batsheva Elran, is the managing entity of Medica III            
 Fund. The principal business address of Medica III Investment is 60C Medinat Hayehudim, Herzliya, 4676670, Israel.                           |

| (7) | Consists of (1) 270,473                                                                                                              
 Ordinary Shares held by SCP Vitalife Partners II L.P., and (2) 130,465 Ordinary Shares held by SCP Vitalife Partners (Israel) II     
 L.P